GoodRx Holdings, Inc. (GDRX) Misses Q2 EPS by 1c

GoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q2 EPS of $0.09, $0.01 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $203.1 million versus the consensus estimate of $205.87 million.

For earnings history and earnings-related data on GoodRx Holdings, Inc. (GDRX) click here.

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• Bimegren Energy (BESS) files $100M mixed shelf
• NeuroSense posts narrower H1 loss, targets Canada drug filing by December